Search research articles
Contact Us
Filters
Showing results (11-20 of 95) with videos related to
Page
of 10
Sort By:
Pharmacological Reviews
|
September 8, 2017
The Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels: from Biophysics to Pharmacology of a Unique Family of Ion Channels
Laura Sartiani, Guido Mannaioni, Alessio Masi, et al.
Plos One
|
March 8, 2013
Effectiveness of the histone deacetylase inhibitor (S)-2 against LNCaP and PC3 human prostate cancer cells
Anna Laurenzana, Manjola Balliu, Cristina Cellai, et al.
Behavioural Brain Research
|
July 8, 2017
Significance of the nicotinic alpha7 receptor in cognition and antipsychotic-like behavior in the rat
Marie-Louise G Wadenberg, Dina Manetti, Maria Novella Romanelli, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
December 28, 2017
Investigation of piperazines as human carbonic anhydrase I, II, IV and VII activators
Andrea Angeli, Niccolò Chiaramonte, Dina Manetti, et al.
Future Medicinal Chemistry
|
February 17, 2018
Designing selective modulators for the nicotinic receptor subtypes: challenges and opportunities
Dina Manetti, Cristina Bellucci, Niccolò Chiaramonte, et al.
Expert Opinion on Drug Discovery
|
July 18, 2022
The piperazine scaffold for novel drug discovery efforts: the evidence to date
Maria Novella Romanelli, Dina Manetti, Laura Braconi, et al.
Bioorganic & Medicinal Chemistry
|
January 10, 2008
Docking analyses on human muscarinic receptors: unveiling the subtypes peculiarities in agonists binding
Giulio Vistoli, Alessandro Pedretti, Silvia Dei, et al.
Archiv Der Pharmazie
|
April 6, 2002
Sigma receptor binding profile of a series of analgesic tropane derivatives
Orazio Prezzavento, Fulvio Gualtieri, Agostino Marrazzo, et al.
Progress in Biophysics and Molecular Biology
|
July 25, 2021
The HCN channel as a pharmacological target: Why, where, and how to block it
Valentina Balducci, Caterina Credi, Leonardo Sacconi, et al.
Molecules (Basel, Switzerland)
|
January 11, 2024
Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011-2023
Maria Novella Romanelli, Laura Braconi, Alessio Gabellini, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 95) with videos related to
Sort By:
Page
of 10
Pharmacological Reviews
|
September 8, 2017
The Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels: from Biophysics to Pharmacology of a Unique Family of Ion Channels
Laura Sartiani, Guido Mannaioni, Alessio Masi, et al.
Plos One
|
March 8, 2013
Effectiveness of the histone deacetylase inhibitor (S)-2 against LNCaP and PC3 human prostate cancer cells
Anna Laurenzana, Manjola Balliu, Cristina Cellai, et al.
Behavioural Brain Research
|
July 8, 2017
Significance of the nicotinic alpha7 receptor in cognition and antipsychotic-like behavior in the rat
Marie-Louise G Wadenberg, Dina Manetti, Maria Novella Romanelli, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
December 28, 2017
Investigation of piperazines as human carbonic anhydrase I, II, IV and VII activators
Andrea Angeli, Niccolò Chiaramonte, Dina Manetti, et al.
Future Medicinal Chemistry
|
February 17, 2018
Designing selective modulators for the nicotinic receptor subtypes: challenges and opportunities
Dina Manetti, Cristina Bellucci, Niccolò Chiaramonte, et al.
Expert Opinion on Drug Discovery
|
July 18, 2022
The piperazine scaffold for novel drug discovery efforts: the evidence to date
Maria Novella Romanelli, Dina Manetti, Laura Braconi, et al.
Bioorganic & Medicinal Chemistry
|
January 10, 2008
Docking analyses on human muscarinic receptors: unveiling the subtypes peculiarities in agonists binding
Giulio Vistoli, Alessandro Pedretti, Silvia Dei, et al.
Archiv Der Pharmazie
|
April 6, 2002
Sigma receptor binding profile of a series of analgesic tropane derivatives
Orazio Prezzavento, Fulvio Gualtieri, Agostino Marrazzo, et al.
Progress in Biophysics and Molecular Biology
|
July 25, 2021
The HCN channel as a pharmacological target: Why, where, and how to block it
Valentina Balducci, Caterina Credi, Leonardo Sacconi, et al.
Molecules (Basel, Switzerland)
|
January 11, 2024
Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011-2023
Maria Novella Romanelli, Laura Braconi, Alessio Gabellini, et al.
Page
of 10